# Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma

> **NCT00849095** · PHASE3 · COMPLETED · sponsor: **Università degli Studi di Ferrara** · enrollment: 860 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** budesonide/formoterol combination (PRN)
- **DRUG:** budesonide/formoterol combination
- **DRUG:** placebo
- **DRUG:** terbutaline

## Key facts

- **NCT ID:** NCT00849095
- **Lead sponsor:** Università degli Studi di Ferrara
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 860 (ACTUAL)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849095, "Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00849095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*